228 related articles for article (PubMed ID: 8227547)
1. Expression of p53 protein in benign and malignant epidermal pathologic conditions.
Helander SD; Peters MS; Pittelkow MR
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):741-8. PubMed ID: 8227547
[TBL] [Abstract][Full Text] [Related]
2. The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma.
Bäckvall H; Wolf O; Hermelin H; Weitzberg E; Pontén F
Br J Dermatol; 2004 Feb; 150(2):259-66. PubMed ID: 14996096
[TBL] [Abstract][Full Text] [Related]
3. p63 expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
[TBL] [Abstract][Full Text] [Related]
4. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
5. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
6. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
Lee YS; Teh M
Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
8. [Elevated p53 protein expression in normal and neoplastic light-exposed epidermis].
Sutter C; Wersin R; Varnai M; Friemann J
Verh Dtsch Ges Pathol; 1994; 78():246-51. PubMed ID: 7533993
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma.
Stephenson TJ; Royds J; Silcocks PB; Bleehen SS
Br J Dermatol; 1992 Dec; 127(6):566-70. PubMed ID: 1476915
[TBL] [Abstract][Full Text] [Related]
10. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.
Ren ZP; Pontén F; Nistér M; Pontén J
Int J Cancer; 1996 Jun; 69(3):174-9. PubMed ID: 8682583
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
12. Possible Involvement of F1F0-ATP synthase and Intracellular ATP in Keratinocyte Differentiation in normal skin and skin lesions.
Xiaoyun X; Chaofei H; Weiqi Z; Chen C; Lixia L; Queping L; Cong P; Shuang Z; Juan S; Xiang C
Sci Rep; 2017 Feb; 7():42672. PubMed ID: 28209970
[TBL] [Abstract][Full Text] [Related]
13. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma gene expression in human non-melanoma skin cancer.
Edwards MJ; Thomas RC; Wong YL
J Cutan Pathol; 2003 Sep; 30(8):479-85. PubMed ID: 12950498
[TBL] [Abstract][Full Text] [Related]
15. Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer.
Duvic M; Helekar B; Schulz C; Cho M; DiSepio D; Hager C; DiMao D; Hazarika P; Jackson B; Breuer-McHam J; Young J; Clayman G; Lippman SM; Chandraratna RA; Robinson NA; Deucher A; Eckert RL; Nagpal S
Clin Cancer Res; 2000 Aug; 6(8):3249-59. PubMed ID: 10955811
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of low-molecular-weight stress protein HSP 27 in normal skin and common cutaneous lesions.
Gandour-Edwards R; McClaren M; Isseroff RR
Am J Dermatopathol; 1994 Oct; 16(5):504-9. PubMed ID: 7802164
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes.
Hochberg M; Gilead L; Markel G; Nemlich Y; Feiler Y; Enk CD; Denichenko P; Karni R; Ingber A
Arch Dermatol Res; 2013 Aug; 305(6):519-28. PubMed ID: 23543219
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases.
Piepkorn M
Am J Dermatopathol; 1996 Apr; 18(2):165-71. PubMed ID: 8739992
[TBL] [Abstract][Full Text] [Related]
20. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
Kerschmann RL; McCalmont TH; LeBoit PE
Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
